Graham J, Earnshaw S, Lim J, Luthra R, Borker R. Cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non-small cell lung cancer with EGFR Exon 19 deletion mutations. JCP. 2016 May;2(4):31-9.
Wallner (MacLeod) S, Kendall P, Hillers V, Bradshaw E, Medeiros LC. Online continuing education course enhances nutrition and health professionals' knowledge of food safety issues of high-risk populations. J Am Diet Assoc. 2007 Aug;107(8):1333-8. doi: 10.1016/j.jada.2007.05.014
Strickland A, Brogan AJ, Krauss J, Martindale R, Cresci G. Is the use of specialized nutritional formulations a cost-effective strategy? A national database evaluation. J Parenter Enter Nutr. 2005 Jan 1;29(1 Suppl):S81-91.